Balyasny Asset Management L.P. Acquires Shares of 650,279 COMPASS Pathways plc (NASDAQ:CMPS)

Balyasny Asset Management L.P. acquired a new stake in COMPASS Pathways plc (NASDAQ:CMPS - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 650,279 shares of the company's stock, valued at approximately $2,458,000. Balyasny Asset Management L.P. owned approximately 0.95% of COMPASS Pathways at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Altium Capital Management LLC acquired a new stake in COMPASS Pathways in the 4th quarter valued at about $5,384,000. Nantahala Capital Management LLC boosted its stake in shares of COMPASS Pathways by 400.0% in the 4th quarter. Nantahala Capital Management LLC now owns 1,000,000 shares of the company's stock valued at $3,780,000 after purchasing an additional 800,000 shares during the last quarter. Affinity Asset Advisors LLC boosted its stake in shares of COMPASS Pathways by 183.0% in the 4th quarter. Affinity Asset Advisors LLC now owns 850,512 shares of the company's stock valued at $3,215,000 after purchasing an additional 550,000 shares during the last quarter. Barclays PLC boosted its stake in shares of COMPASS Pathways by 2.1% in the 4th quarter. Barclays PLC now owns 419,194 shares of the company's stock valued at $1,585,000 after purchasing an additional 8,718 shares during the last quarter. Finally, Marshall Wace LLP bought a new position in shares of COMPASS Pathways in the 4th quarter valued at about $1,395,000. Institutional investors and hedge funds own 46.19% of the company's stock.

COMPASS Pathways Stock Performance

Shares of CMPS stock opened at $3.91 on Tuesday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 8.91 and a current ratio of 8.91. COMPASS Pathways plc has a 52 week low of $2.49 and a 52 week high of $8.54. The company's 50 day moving average price is $3.34 and its two-hundred day moving average price is $3.99. The company has a market capitalization of $363.04 million, a P/E ratio of -1.78 and a beta of 2.27.

COMPASS Pathways (NASDAQ:CMPS - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.44) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.47) by $0.03. On average, analysts expect that COMPASS Pathways plc will post -2.33 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on CMPS shares. HC Wainwright reaffirmed a "buy" rating and issued a $45.00 target price on shares of COMPASS Pathways in a research note on Monday. Stifel Nicolaus started coverage on shares of COMPASS Pathways in a research note on Thursday, February 27th. They issued a "buy" rating and a $11.00 target price on the stock. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $18.00 target price on shares of COMPASS Pathways in a research note on Wednesday, January 15th. Canaccord Genuity Group reduced their target price on shares of COMPASS Pathways from $23.00 to $15.00 and set a "buy" rating on the stock in a research note on Friday, February 28th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating on shares of COMPASS Pathways in a research note on Friday, March 28th. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $20.20.

COMPASS Pathways Company Profile

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.

Want to see what other hedge funds are holding CMPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for COMPASS Pathways plc (NASDAQ:CMPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.